ADC Therapeutics Statistics
Total Valuation
ADCT has a market cap or net worth of $132.77 million. The enterprise value is $351.86 million.
| Market Cap | 132.77M |
| Enterprise Value | 351.86M |
Important Dates
The last earnings date was Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 127.67 million shares outstanding. The number of shares has increased by 38.27% in one year.
| Current Share Class | 127.67M |
| Shares Outstanding | 127.67M |
| Shares Change (YoY) | +38.27% |
| Shares Change (QoQ) | +21.90% |
| Owned by Insiders (%) | 3.84% |
| Owned by Institutions (%) | 33.64% |
| Float | 88.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.64 |
| Forward PS | 1.54 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.03
| Current Ratio | 3.03 |
| Quick Ratio | 2.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.80 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -19.57% |
| Return on Invested Capital (ROIC) | -25.47% |
| Return on Capital Employed (ROCE) | -48.72% |
| Weighted Average Cost of Capital (WACC) | 10.55% |
| Revenue Per Employee | $412,352 |
| Profits Per Employee | -$502,114 |
| Employee Count | 193 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 7.83 |
Taxes
| Income Tax | -404,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.30% in the last 52 weeks. The beta is 1.83, so ADCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.83 |
| 52-Week Price Change | -67.30% |
| 50-Day Moving Average | 1.14 |
| 200-Day Moving Average | 3.08 |
| Relative Strength Index (RSI) | 43.77 |
| Average Volume (20 Days) | 1,467,436 |
Short Selling Information
The latest short interest is 5.09 million, so 3.99% of the outstanding shares have been sold short.
| Short Interest | 5.09M |
| Short Previous Month | 5.99M |
| Short % of Shares Out | 3.99% |
| Short % of Float | 5.75% |
| Short Ratio (days to cover) | 4.74 |
Income Statement
In the last 12 months, ADCT had revenue of $79.58 million and -$96.91 million in losses. Loss per share was -$0.65.
| Revenue | 79.58M |
| Gross Profit | -9.23M |
| Operating Income | -94.06M |
| Pretax Income | -97.31M |
| Net Income | -96.91M |
| EBITDA | -93.71M |
| EBIT | -94.06M |
| Loss Per Share | -$0.65 |
Balance Sheet
The company has $219.11 million in cash and $438.19 million in debt, with a net cash position of -$219.08 million or -$1.72 per share.
| Cash & Cash Equivalents | 219.11M |
| Total Debt | 438.19M |
| Net Cash | -219.08M |
| Net Cash Per Share | -$1.72 |
| Equity (Book Value) | -228.21M |
| Book Value Per Share | -1.79 |
| Working Capital | 175.38M |
Cash Flow
In the last 12 months, operating cash flow was -$102.27 million and capital expenditures -$32,000, giving a free cash flow of -$102.30 million.
| Operating Cash Flow | -102.27M |
| Capital Expenditures | -32,000 |
| Depreciation & Amortization | 353,500 |
| Net Borrowing | n/a |
| Free Cash Flow | -102.30M |
| FCF Per Share | -$0.80 |
Margins
Gross margin is -11.59%, with operating and profit margins of -118.19% and -121.77%.
| Gross Margin | -11.59% |
| Operating Margin | -118.19% |
| Pretax Margin | -122.28% |
| Profit Margin | -121.77% |
| EBITDA Margin | -117.75% |
| EBIT Margin | -118.19% |
| FCF Margin | n/a |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.27% |
| Shareholder Yield | -38.27% |
| Earnings Yield | -74.42% |
| FCF Yield | -78.56% |
Analyst Forecast
The average price target for ADCT is $3.33, which is 220.19% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.33 |
| Price Target Difference | 220.19% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 30.23% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADCT has an Altman Z-Score of -8.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.02 |
| Piotroski F-Score | 3 |